DXCM Dexcom Inc

DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.

$356.32  -12.38 (-3.36%)
As of 03/04/2021 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Large cap
Health Care
Diagnostics & Research
USA
USA
04/14/2005
96,177,363
803,118
$35,460,593,738
0.00%
SEC Edgar Online
10-Q
10-K
252131107
US2521311074
B0796X4

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
71.86
19.40
18.40
27.02%
25.62%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy